NCT00078975: 3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer |
|
|
| Completed | 2 | 26 | Canada | gemcitabine hydrochloride, triapine | University Health Network, Toronto, National Cancer Institute (NCI) | Pancreatic Cancer | 12/05 | 01/09 | | |
NCT00085371: Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas |
|
|
| Completed | 2 | 116 | US | triapine | National Cancer Institute (NCI) | Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer | 07/06 | | | |
NCT00081276: 3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer |
|
|
| Completed | 2 | 48 | US | triapine, 3-AP, OCX-191, cisplatin, CACP, CDDP, CPDD, DDP, laboratory biomarker analysis | National Cancer Institute (NCI) | Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer | 01/07 | | | |